Prevalence of new-onset diabetes mellitus after kidney transplantation: a systematic review and meta-analysis
- 20 March 2024
- journal article
- review article
- Published by Springer Nature in Acta Diabetologica
- Vol. 61 (7) , 809-829
Abstract
Aims Post-transplant diabetes is a prevalent and consequential complication following kidney transplantation, which significantly augments the risk of cardiovascular disease, graft loss, infection, and mortality, thereby profoundly impacting both graft and patient survival. However, the early stages of post-transplant diabetes often go unnoticed or receive inadequate management. Consequently, this study systematically assesses the incidence of new-onset diabetes after kidney transplantation with the aim to enhance medical staff awareness regarding post-transplantation diabetes and provide clinical management guidance. Methods We conducted a comprehensive search across multiple databases including PubMed, Web of Science, Embase, The Cochrane Library, CNKI, Wanfang, VIP, and SinoMed until September 21, 2023. Data extraction was performed using standardized tables and meta-analysis was conducted using Stata 16.0 software. A random effects model was employed to estimate the combined prevalence along with its corresponding 95% confidence interval. The source of heterogeneity was explored using subgroup analysis and sensitivity analysis, while publication bias was assessed through funnel plot and Egger's test. This study has been registered with PROSPERO under the registration number CRD42023465768. Results This meta-analysis comprised 39 studies with a total sample size of 16,584 patients. The prevalence of new-onset diabetes after transplantation was found to be 20% [95% CI (18.0, 22.0)]. Subgroup analyses were conducted based on age, gender, body mass index, family history of diabetes, type of kidney donor, immunosuppressive regimen, acute rejection episodes, hepatitis C infection status and cytomegalovirus infection. Conclusions The incidence of post-kidney transplantation diabetes is substantial, necessitating early implementation of preventive and control measures to mitigate its occurrence, enhance prognosis, and optimize patients' quality of life. Clinical trial registration: PROSPERO: CRD42023465768.Keywords
Funding Information
- National Major Science and Technology Projects of China (2020YFC2003104)
This publication has 103 references indexed in Scilit:
- Postoperative fasting plasma glucose and family history diabetes mellitus can predict post-transplantation diabetes mellitus in kidney transplant recipientsEndocrine, 2023
- Association between preoperative lipid profiles and new‐onset diabetes after transplantation in Chinese kidney transplant recipients: A retrospective cohort studyJournal of Clinical Laboratory Analysis, 2021
- Post-Transplantation Diabetes MellitusDiabetes Therapy, 2020
- Testosterone in renal transplant patients: effect on body composition and clinical parametersJournal Of Nephrology, 2018
- Post-transplantation diabetes in kidney transplant recipients: an update on management and preventionActa Diabetologica, 2018
- Pharmacogenetics of post-transplant diabetes mellitus in children with renal transplantation treated with tacrolimusPediatric Nephrology, 2018
- Prevalence of Depression, Depressive Symptoms, and Suicidal Ideation Among Medical StudentsJAMA, 2016
- Endothelial nitric oxide synthase gene intron 4 polymorphism predicts new onset diabetes mellitus after transplantation in kidney allograft recipients treated with cyclosporin AInternational Urology and Nephrology, 2010
- Diabetes mellitus after kidney transplantation: Role of the impaired fasting glucose in the outcome of kidney transplantationJournal of Endocrinological Investigation, 2009
- Risk Factors and Incidence of Posttransplant Diabetes Mellitus in Mexican Kidney RecipientsArchives of Medical Research, 2006